RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Neurofibroma: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Consensus recommendations for neurofibromatosis type 1 management in Asia Pacific.
Berman Yemima et al., iScience (16 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42866620/
- 2.
The 'bag of worms' lesion: plexiform neurofibroma with neurofibromatosis type I in a paediatric patient.
Gandevivala Adil et al., BMJ case reports (16 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42887922/
- 3.
Targeted pharmacotherapy of NF1-associated plexiform neurofibromas: current evidence and future perspectives.
Fertitta Laura et al., Expert opinion on pharmacotherapy (15 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42872421/
- 4.
A Characterisation of Spinal Abnormalities in a Cohort with Neurofibromatosis Type 1 with Dural Ectasia.
Sial Moska et al., World neurosurgery (15 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42880702/
- 5.
Diagnosis and surgical treatment of cutaneous neurofibroma in a goldfish ( Carassius auratus )
Luz Zoraya Beatriz Duarte-Rodríguez et al., Veterinary Record Case Reports (14 October 2026)
https://doi.org/10.1002/vrc2.70632
Clinical Trials : Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
NCT06961565 · Recruiting · Phase 1 · Pasithea Therapeutics Corp.
Ages 18 and over
https://clinicaltrials.gov/study/NCT06961565
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Neurofibroma
A neurofibroma is a non-cancerous tumour that grows from the cells and tissue surrounding peripheral nerves. It can appear as a single lump on or under the skin, or as larger growths along deeper nerves. Many people with neurofibromas have neurofibromatosis type 1, though single tumours can occur without it. Management depends on symptoms and may include monitoring, surgery or targeted medicines.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Neurofibromatosis type 1 (NF1) is a complex multisystem disorder requiring coordinated multidisciplinary care. This study aimed to develop consensus recommendations for NF1 management in the Asia-Pacific region. A modified Delphi process involving two survey rounds and a virtual meeting was conducted with experts from nine countries. A total of 141 statements were evaluated using a 9-point Likert scale with a 75% consensus threshold. Consensus was achieved across key domains including diagnosis, genetic testing, surveillance, and management. Experts emphasized the importance of multidisciplinary care, risk-adapted surveillance, and integration of genetic counseling and imaging in clinical practice. These findings provide regionally relevant guidance to support consistent and practical NF1 management across diverse healthcare systems.
Common Questions
What is Neurofibroma?
A neurofibroma is a non-cancerous tumour that grows from the cells and tissue surrounding peripheral nerves. It can appear as a single lump on or under the skin, or as larger growths along deeper nerves. Many people with neurofibromas have neurofibromatosis type 1, though single tumours can occur without it. Management depends on symptoms and may include monitoring, surgery or targeted medicines.
How many clinical trials are available for Neurofibroma?
RareWays currently indexes 119 clinical trials for Neurofibroma, of which 16 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Neurofibroma come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Neurofibroma.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.